trending Market Intelligence /marketintelligence/en/news-insights/trending/EKdaznpZ8wDZbv26zmHDIA2 content esgSubNav
In This List

VANC Pharmaceuticals to raise C$1.3M via private placement

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


VANC Pharmaceuticals to raise C$1.3M via private placement

Vanc Pharmaceuticals Inc. plans to raise C$1.3 million in a nonbrokered private placement of company units.

The company will issue 5,416,666 units at 24 Canadian cents apiece with each unit comprising a common share and one transferable share purchase warrant.

Each warrant is exercisable for conversion into a common share for 32 Canadian cents within 60 months from the date of issue.

"With this round of financing we will be building inventory and adding to our existing sales and marketing team to introduce our generic drug portfolio along with our OTC products to the Canadian market," VANC's interim CEO, Bob Rai, said in a statement.